97 related articles for article (PubMed ID: 15303248)
1. Milnacipran treatment of a terminally ill cancer patient with major depressive disorder.
Sato K; Higuchi H; Yoshida K; Takahashi H; Shimizu T; Watanabe J
Hum Psychopharmacol; 2004 Aug; 19(6):431-2. PubMed ID: 15303248
[No Abstract] [Full Text] [Related]
2. No predictors of antidepressant patient response to milnacipran were obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale in Japanese patients with major depressive disorders.
Higuchi H; Sato K; Yoshida K; Takahashi H; Kamata M; Otani K; Yamaguchi N
Psychiatry Clin Neurosci; 2008 Apr; 62(2):197-202. PubMed ID: 18412843
[TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression.
Lee MS; Ham BJ; Kee BS; Kim JB; Yeon BK; Oh KS; Oh BH; Lee C; Jung HY; Chee IS; Choe BM; Paik IH
Curr Med Res Opin; 2005 Sep; 21(9):1369-75. PubMed ID: 16197655
[TBL] [Abstract][Full Text] [Related]
4. Resolution of sexual dysfunction during acute treatment of major depression with milnacipran.
Baldwin D; Moreno RA; Briley M
Hum Psychopharmacol; 2008 Aug; 23(6):527-32. PubMed ID: 18536065
[TBL] [Abstract][Full Text] [Related]
5. The clinical use of milnacipran for depression.
Morishita S; Arita S
Eur Psychiatry; 2003 Feb; 18(1):34-5. PubMed ID: 12648895
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of milnacipran on cognitive dysfunction with post-stroke depression: preliminary open-label study.
Sato S; Yamakawa Y; Terashima Y; Ohta H; Asada T
Psychiatry Clin Neurosci; 2006 Oct; 60(5):584-9. PubMed ID: 16958942
[TBL] [Abstract][Full Text] [Related]
7. Levomilnacipran and Vortioxetine for Adults with Major Depressive Disorder.
Scarff JR
J S C Med Assoc; 2015 Dec-2016 Jan; 111(4):131-3. PubMed ID: 27141705
[No Abstract] [Full Text] [Related]
8. Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients.
Naito S; Sato K; Yoshida K; Higuchi H; Takahashi H; Kamata M; Ito K; Ohkubo T; Shimizu T
Psychiatry Clin Neurosci; 2007 Aug; 61(4):421-7. PubMed ID: 17610668
[TBL] [Abstract][Full Text] [Related]
9. Hypertension induced by regular doses of milnacipran: a case report.
de Toledo Ferraz Alves TC; Guerra de Andrade A
Pharmacopsychiatry; 2007 Jan; 40(1):41-2. PubMed ID: 17327962
[No Abstract] [Full Text] [Related]
10. Vilazodone, levomilnacipran and vortioxetine for major depressive disorder: the 15-min challenge to sort these agents out.
Citrome L
Int J Clin Pract; 2015 Feb; 69(2):151-5. PubMed ID: 25627335
[No Abstract] [Full Text] [Related]
11. Lithium augmentation in milnacipran-refractory depression for the prevention of relapse following electroconvulsive therapy.
Okamoto H; Shimizu E; Ozawa K; Hashimoto K; Iyo M
Aust N Z J Psychiatry; 2005; 39(1-2):108. PubMed ID: 15660714
[No Abstract] [Full Text] [Related]
12. A case of adult attention-deficit/hyperactivity disorder alleviated by milnacipran.
Kako Y; Niwa Y; Toyomaki A; Yamanaka H; Kitagawa N; Denda K; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):772-5. PubMed ID: 17300859
[TBL] [Abstract][Full Text] [Related]
13. Effect of Milnacipran on Plasma Level of Vascular Endothelial Growth Factor in Major Depression.
Yoshimura R; Ikenouchi A; Okamoto N
Psychopharmacol Bull; 2022 Oct; 52(4):106-108. PubMed ID: 36339278
[No Abstract] [Full Text] [Related]
14. The Editor's Roundtable: major depression in patients with coronary heart disease.
Friedewald VE; Arnold LW; Carney RM; Jaffe AS; Sheps DS; Roberts WC
Am J Cardiol; 2007 Feb; 99(4):519-29. PubMed ID: 17293197
[No Abstract] [Full Text] [Related]
15. The prevalence and pharmacotherapy of depression in cancer patients.
Ng CG; Boks MP; Zainal NZ; de Wit NJ
J Affect Disord; 2011 Jun; 131(1-3):1-7. PubMed ID: 20732716
[TBL] [Abstract][Full Text] [Related]
16. Management of major depressive disorder in primary care.
Dantz B
Mich Med; 2008; 107(3):24-6. PubMed ID: 18700401
[No Abstract] [Full Text] [Related]
17. Treatment of neuropsychiatric symptoms associated with euthyroid Hashimoto thyroiditis with antidepressants: a case report.
Andreou C; Bozikas VP; Lagoudis A; Paspali D; Fokas K
Gen Hosp Psychiatry; 2009; 31(2):199-200. PubMed ID: 19269547
[No Abstract] [Full Text] [Related]
18. Initial treatment approaches for patients with major depressive disorder.
Papakostas GI
J Clin Psychiatry; 2009 Jun; 70(6):e18. PubMed ID: 19573474
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety of milnacipran treatment for a patient with delusional disorder, somatic type taking multiple medications for concomitant physical diseases.
Otani K; Miura Y; Suzuki A; Kinoshita O
Clin Neuropharmacol; 2010 Jul; 33(4):212-3. PubMed ID: 20386103
[TBL] [Abstract][Full Text] [Related]
20. A case of temporo-mandibular disorder with fibromyalgia treated with the antidepressant, milnacipran.
Toyofuku A; Miyako H
Hum Psychopharmacol; 2004 Jul; 19(5):357-8. PubMed ID: 15252831
[No Abstract] [Full Text] [Related]
[Next] [New Search]
